Bulletin
Investor Alert

NeuBase Therapeutics Inc.

NAS: NBSE

GO
/marketstate/country/us

After Hours

/zigman2/quotes/206101919/composite

$

2.68

Change

-0.01 -0.37%

Volume

Volume 1,500

Dec 3, 2021, 4:12 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/206101919/composite

Previous close

$ 2.89

$ 2.69

Change

-0.20 -6.92%

Day low

Day high

$2.68

$2.88

Open
Open: 2.88

52 week low

52 week high

$2.66

$12.89

Open

Market cap

$88.01M

Average volume

162,372

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-0.90

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/nbse

MarketWatch News on NBSE

  1. NeuBase Therapeutics started at outperform with $14 stock price target at Oppenheimer

    7:40 a.m. Nov. 21, 2019

    - Tomi Kilgore

  2. Carnegie Mellon University Is a Big Backer of This Biotech Stock

    6:00 a.m. July 27, 2019

    - Barron's Online

  3. Ohr Pharmaceutical downgraded to hold from buy at Brean Capital

    7:38 a.m. Aug. 10, 2016

    - Tomi Kilgore

  4. Charting the Market

    12:10 a.m. July 18, 2015

    - Barron's Online

  5. In focus: New highs seem unlikely

    5:33 p.m. July 15, 2015

    - Lawrence G. McMillan

  6. Three health-care deals today are paying huge premiums

    8:26 a.m. March 31, 2015

    - Philip van Doorn

  7. Charting the Market

    11:40 p.m. March 6, 2015

    - Barron's Online

  8. Charting the Market

    11:32 p.m. June 27, 2014

    - Barron's Online

Analyst Ratings

/news/nonmarketwatch/company/us/nbse

Other News on NBSE

  1. Tracking David Einhorn's Portfolio - Q3 2021 Update

    10:16 p.m. Nov. 17, 2021

    - Seeking Alpha

  2. Tracking David Einhorn's Portfolio - Q2 2021 Update

    1:00 a.m. Sept. 7, 2021

    - Seeking Alpha

  3. 10-Q: NEUBASE THERAPEUTICS, INC.

    3:14 p.m. Aug. 13, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  4. 10-Q: NEUBASE THERAPEUTICS, INC.

    5:09 a.m. May 14, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  5. NeuBase Therapeutics slumps on launching stock offering

    3:07 p.m. April 21, 2021

    - Seeking Alpha

  6. Tracking David Einhorn's Portfolio - Q4 2020 Update

    4:42 a.m. March 30, 2021

    - Seeking Alpha

  7. Neubase Therapeutics (NBSE) Investor Presentation - Slideshow

    11:42 a.m. March 18, 2021

    - Seeking Alpha

  8. 10-Q: NEUBASE THERAPEUTICS, INC.

    5:10 p.m. Feb. 11, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  9. NeuBase snaps gene modulating technology from Vera Therapeutics

    9:17 a.m. Jan. 28, 2021

    - Seeking Alpha

  10. Greenlight Capital Q4 2020 Letter

    2:27 p.m. Jan. 22, 2021

    - Seeking Alpha

  11. David Einhorn's Value Strategy Yields Results While Shorts Drag

    11:14 a.m. Jan. 22, 2021

    - GuruFocus.com

  12. 10-K: NEUBASE THERAPEUTICS, INC.

    4:34 p.m. Dec. 23, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  13. APHA, TLRY among premarket gainers

    8:25 a.m. Dec. 16, 2020

    - Seeking Alpha

  14. Tracking David Einhorn's Portfolio - Q3 2020 Update

    8:42 a.m. Nov. 18, 2020

    - Seeking Alpha

  15. Loading more headlines...
/news/pressrelease/company/us/nbse

Press Releases on NBSE

  1. Friday Sector Laggards: Biotechnology, Publishing Stocks

    12:57 p.m. Oct. 15, 2021

    - MarketNewsVideo.com

  2. Loading more headlines...

Rates »

Trending Tickers
  • /zigman2/quotes/201786389/composite USA+0.11%
  • /zigman2/quotes/205971581/composite VIXM+1.50%
  • /zigman2/quotes/204412041/composite KMX+0.98%
  • /zigman2/quotes/205782082/composite IT-0.70%
  • /zigman2/quotes/200387963/composite LINK+1.77%
X
Powered by StockTwits
Link to MarketWatch's Slice.